ArticleUpdates in surgery2026
Skin-to-portal junction distance as a simple CT-based predictor of pancreatic fistula after pancreaticoduodenectomy: a validated model.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a significant concern after pancreaticoduodenectomy (PD), increasing morbidity and mortality. This retrospective study evaluated the skin-to-portal junction distance (SJD), a simple CT-based metric, as a predictor of CR-POPF and developed a validated predictive model for risk stratification. The study included 305 patients undergoing open PD, divided into training (n = 214) and validation (n = 91) cohorts. Sex-specific SJD cutoffs were determined using receiver operating characteristic analysis. Logistic regression identified CR-POPF risk factors and built the model, assessed by area under the curve (AUC), calibration plots, and decision curve analysis (DCA). CR-POPF occurred in 23.9% of patients overall, with incidences of 23.4% and 25.3% in the training and validation cohorts, respectively. High SJD (≥ 78 mm for males, ≥ 64 mm for females; odds ratio [OR] 5.140), main pancreatic duct diameter ≤ 3 mm (OR 2.720), non-pancreatic ductal adenocarcinoma (OR 3.820), and soft pancreatic texture (OR 2.660) were independent predictors. The model achieved AUCs of 0.832 in the training cohort and 0.806 in the validation cohort, with good calibration and clinical utility as shown by DCA. These results compared favorably with the Fistula Risk Score (FRS) and alternative-FRS. The high SJD group had a higher incidence of CR-POPF (36.3% vs. 14.1%, p < 0.001), longer operative time (p = 0.004), greater blood loss (p = 0.047), and more major complications of Clavien-Dindo grade ≥ III (p < 0.001). SJD is a simple, objective predictor of CR-POPF. The validated model facilitates perioperative risk stratification; however, external validation is needed.
Indexed as
Identifiers
40965752What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.